ARKG vs IXUS
ARK Genomic Revolution ETF vs iShares Core MSCI Total International Stock ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
IXUS—
iShares Core MSCI Total International Stock ETF
Non-US equities across developed and emerging markets.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | IXUS |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
IXUS top holdings
Holdings data unavailable for IXUS.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About IXUS
IXUS (iShares Core MSCI Total International Stock ETF) is Non-US equities across developed and emerging markets.